Design issues for drug epidemiology (Q34078588)

30 July 2017

1 reference

title

Design issues for drug epidemiology (English)

1 reference

30 July 2017

1 reference

A D McMahon

1

1 reference

30 July 2017

T M MacDonald

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

British Journal of Clinical Pharmacology

30 July 2017

published in

1 reference

30 July 2017

volume

50

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

419-425

1 reference

Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Record-linkage for pharmacovigilance in Scotland

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Presentation: Epidemiology and public health: is a new paradigm needed or a new ethic?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Generalisation and extrapolation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Use of the UK General Practice Research Database for pharmacoepidemiology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Evidence in medicine: invited commentary

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Pharmacovigilance in the 1990s

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Why we need observational studies to evaluate the effectiveness of health care

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Why the Safety Assessment of Marketed Medicines (SAMM) guidelines are needed

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Double standards, scientific methods, and epidemiologic research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

The need for randomization in the study of intended effects.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Clinical biostatistics. XX. The epidemiologic trohoc, the ablative risk ratio, and "retrospective" research.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

The "case-control" study: valid selection of subjects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Avoidance of bias in cohort studies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Is the randomized controlled trial the real paradigm in epidemiology?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Striving to deconfound the fundamentals of epidemiologic study design

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

The clinical trial as a paradigm for epidemiologic research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Behavior of the exposure odds ratio in a case-control study when the hazard function is not constant over time.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Problems with using observational databases to compare treatments

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Developing improved observational methods for evaluating therapeutic effectiveness.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Taxonomic axes of epidemiologic study designs: a refutationist perspective.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Falsificationism and clinical trials.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Guide to interpreting and evaluating the pharmacoepidemiologic literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Epidemiologic methods in clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014406

Controls who experienced hypothetical causal intermediates should not be excluded from case-control studies

5 July 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00289.X

Principles of epidemiological research on adverse and beneficial drug effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00289.X

Experiment and observation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00289.X

THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00289.X

Selection of controls in case-control studies. I. Principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00289.X

A cohort study (with re-sampled comparator groups) to measure the association between new NSAID prescribing and upper gastrointestinal hemorrhage and perforation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00289.X

Clinical trials and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00289.X

Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research

21 January 2018

1 reference

12 December 2020

A collection of 56 topics with contradictory results in case-control research

1 reference

12 December 2020

Post-marketing studies of drug efficacy: why?

1 reference

12 December 2020

Case-control studies in the evaluation of drug-induced illness

1 reference

12 December 2020

Tying clinical research to patient care by use of an observational database

1 reference

12 December 2020

Post-marketing studies of drug efficacy: how?

1 reference

12 December 2020

The evolution of clinical practice and time trends in drug effects

1 reference

12 December 2020

A method of pharmacoepidemiologic analysis that uses computerized Medicaid

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Cohorts versus dynamic populations: a dissenting view

1 reference

12 December 2020

Classification schemes for epidemiologic research designs

1 reference

12 December 2020

Postmarketing studies of drug efficacy: when must they be randomized?

1 reference

12 December 2020

Subject selection in hospital-based case-control studies

1 reference

12 December 2020

Drug exposure risk windows and unexposed comparator groups for cohort studies in pharmacoepidemiology

1 reference

12 December 2020

10.1046/J.1365-2125.2000.00289.X

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference